Clinical Trial Update: Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm

View source ↗

Summary

A clinical trial is evaluating the PET imaging agent fluoroethyltyrosine for intracranial neoplasms and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Neoplasm

Drugs mentioned

• Fluoroethyltyrosine (fluoroethyltyrosine)

Snippet

Sponsor: Thomas Hope | Conditions: Intracranial Neoplasm | Status: RECRUITING